논문번호 | 102 | ||
논문제목(영문) | Are Drug-Eluting Stents Better In Safety and Efficacy Than Bare-Metal Stents In Patients With Acute Myocardial Infarction?: 3-Years Follow-up. | ||
국내외구분 | 국외 | SCI여부 | SCI(E) |
연구책임자역할 | 공저자 | ||
주저자명 | Lee KH | ||
교신저자명 | Ahn Y | ||
공동저자명 | Lee KH, Ahn Y, Yoon NS, Yoon HJ, Hong YJ, Kim KH, Park HW, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC; | ||
게제년월일 | 2011-01-06 | ||
ISSN | 1349-2365 | ||
Impact Factor | 1.073 | ||
학술지명 | International heart journal | ||
서지사항 | 0집 / 52권 / 2호, 페이지(78 - 83) | ||
요약초록문 (Abstract) 입력 |
Questions about the long-term safety over the beneficial effects of drug-eluting stents (DES) have grown. We compared the long-term safety and efficacy of DES and bare-metal stents (BMS) in patients with acute myocardial infarction (AMI). A total of 1,017 AMI patients treated with stent implantation were followed for 3 years; 660 (64.9%) patients were treated with at least one DES and 357 (35.1%) patients were treated with at least one BMS. The primary endpoints were total mortality and the composite of major adverse cardiac events (MACE) including total mortality, re-MI, target lesion revascularization (TLR), and coronary artery bypass graft. At 3-years, the overall risks of cardiac and all-cause mortality were not different between the groups. However, the use of DES significantly decreased TLR (17.4% versus 7.1%, adjusted hazard ratio [HR] 0.44, 95% confidence interval [CI] 0.30 to 0.65) and the composite of MACEs (27.2% versus 19.5%, adjusted HR 0.65, 95% CI 0.48 to 0.87) with no differences in MI. The risk of MACE up to 1 year (HR 0.56, 95% CI 0.39 to 0.80) was higher in BMS patients, whereas from 1 year to 2 years (HR 0.55, 95% CI 0.27 to 1.10) and from 2 years to 3 years (HR 1.13, 95% CI 0.56 to 2.28), it was similar between the groups. The use of DES does not have a significant effect on overall long-term clinical survival compared with that of BMS in AMI patients. However, the use of DES reduced the need for re-intervention and the risk of MACE, mostly within 1 year. | ||
파일 |
C102.+Int+Heart+J+2011;52(2)78-83..pdf (562.5K) DATE : 2021-05-25 14:27:03 |
전라남도 장성군 남면 삼태리 산 109 나노바이오연구원 3층 306호 TEL : 061-392-6243 Fax: 061-392-6243
Copyright ⓒ 2014 Korea Cardiovascular Stent Research Institute. All right Reserved